As BMI emerged as an influential component of our study, we evaluated P2X7 expression in patients classified accordingly to their BMI (Normal weight ≤ 24.9; Overweight 25-29.9, Obesity ≥ 30), and whether they also presented T2DM. Here, P2RX7 is linked to obesity due to melanocortin 4 receptor deficiency.